Industry News
ATSE appoints CEO
The Australian Academy of Technological Sciences and Engineering (ATSE) has appointed Dr Trevor Evans as chief executive officer, commencing 1 July 2007.
[ + ]Premier to lead biotech delegation to Boston
Victoria’s biotechnology sector will showcase its strengths when Premier Steve Bracks and Innovation Minister John Brumby lead a delegation of more than 150 businesses to BIO 2007 in Boston.
[ + ]Come in Cell 42, your time is up
The stem cell theory of cancer is transforming medical science's understanding of the origins, development and diversity of cancers, and why cancer therapies are so variable in outcome. [ + ]
Registrations open for ISSCR annual meeting
The organisers of the International Society of Stem Cell Research 5th Annual Meeting wish to welcome delegates to the 5th ISSCR Annual Meeting to take place 17-21 June 2007 at the Cairns Convention Centre, Cairns, Queensland.
[ + ]Inspiration through innovation
NSW will have a chance to enter the world of innovation and entrepreneurship as the annual Australian Innovation Festival rolls into its sixth year.
[ + ]Scientists discover new virus
Scientists have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.
[ + ]Research unravels the secrets of salt and taste
New research into the molecular basis of salty taste has been released by the Nestlé Research Center in Switzerland.
[ + ]Genetic interactions determine hair and skin colour
Queensland researcher Richard Sturm is looking at how various alleles interact to influence eye, hair and skin colour. The research is of particular importance in understanding skin cancer risk in European populations. [ + ]
BIO profile: Nucleus network: networking clinical trials
While Australia has always had a strong and influential basic science base, getting candidates through the trials process to market has long been seen as our stumbling block. A not-for-profit clinical trial network is set to change all of that. [ + ]
BIO profile: Q-Pharm expands service range
Clinical trials specialist Q-Pharm has recently forged two important collaborations with international companies which will enable it to extend its services. [ + ]
BIO profile: Queensland Clinical Trials Network
The not-for-profit Queensland Clinical Trials Network will be exhibiting at BIO 2007. [ + ]
Robotic microbiological instrumentation license agreement signed
LabTech Systems and bioMérieux have announced that they have signed an exclusive worldwide license agreement for LabTech Systems’ automated pre-poured media (PPM) streaker known as MicroStreak.
[ + ]Disrupting interactions sends Progen's stocks sky-high
The share price of Queensland biotech company Progen Industries has almost tripled in less than six months following promising Phase II clinical trial results for its lead cancer compound and the expectation of more good news in the near future. [ + ]
BIO profile: Top down carbohydrate chemistry
Fucoidans are a family of polysaccharides that can act, amongst other things, as immunomodulators, selectin antagonists, viral attachment inhibitors and receptor blockers. And they are sourced directly from seaweed. [ + ]
Minority groups not genetically prone to diabetes
A study by Australian and US researchers is helping dispel the 40-year-old ‘thrifty genotype theory’ – that certain minority groups are genetically prone to diabetes.
[ + ]